Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

Therapeutic drug monitoring (TDM) in cancer, while imperative, has been challenging due to inter-patient variability in drug pharmacokinetics. Additionally, most pharmacokinetic monitoring is done by assessments of the drugs in plasma, which is not an accurate gauge for drug concentrations in target...

Full description

Bibliographic Details
Main Authors: Jay V. Shah, Amber Gonda, Rahul Pemmaraju, Aishwarya Subash, Carolina Bobadilla Mendez, Marissa Berger, Xinyu Zhao, Shuqing He, Richard E. Riman, Mei Chee Tan, Mark C. Pierce, Prabhas V. Moghe, Vidya Ganapathy
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Molecular Biosciences
Subjects:
tumor therapy monitoring
rare earths
shortwave infrared imaging
nanotechnology
theranostic
NIR-II bioimaging
Online Access:https://www.frontiersin.org/article/10.3389/fmolb.2020.569415/full

Internet

https://www.frontiersin.org/article/10.3389/fmolb.2020.569415/full

Similar Items